Jci_page_head_homepage_01 Jci_page_head_homepage_02
David Patsouris, Stéphane Mandard, Peter J. Voshol, Pascal Escher, Nguan Soon Tan, Louis M. Havekes, Wolfgang Koenig, Winfried März, Sherrie Tafuri, Walter Wahli, Michael Müller, Sander Kersten
Published in Volume 114, Issue 1
J Clin Invest. 2004; 114(1):94–103 doi:10.1172/JCI20468
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6

Decreased hepatic glucose production and increased insulin sensitivity in PPARα-null mice. Wild-type and PPARα-null mice administered Wy14643 and fasted were analyzed by hyperinsulinemic clamp technique. (A) Hepatic glucose production under basal and hyperinsulinemic conditions. (B) Percentage of inhibition of hepatic glucose production by insulin. (C) Whole-body glucose utilization under basal and hyperinsulinemic conditions. (D) Percentage of stimulation of whole-body glucose utilization by insulin. Differences between genotypes were statistically significant for all variables except glucose utilization under hyperinsulinemic conditions. P < 0.05, Mann-Whitney U test. Error bars represent SEM.